In Segment A, individuals will acquire various doses and schedules of oral ABBV-744 tablet to detect safe dosing regimen. More contributors will likely be enrolled within the identified monotherapy dosign regimen. In Section B, members will get oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section C, https://angelosetep.blogolenta.com/28831915/5-easy-facts-about-is-abbv-744-effective-for-hematologic-cancers-described